Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Predicting Products: Substitution vs. Elimination02:52

Predicting Products: Substitution vs. Elimination

14.8K
When a nucleophile and an alkyl halide react, nucleophilic substitution and β-elimination reactions compete to generate products.
The following factors can influence the mechanisms competing against each other:
14.8K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

17.3K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.3K
Drug Product Stability01:16

Drug Product Stability

256
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
256
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

45.7K
VSEPR Theory for Determination of Electron Pair Geometries
45.7K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

251
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
251
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

271
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery room resuscitation of conjoined twins.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Revisiting fundoplication in esophageal atresia: Implications for nutrition, stricture management, and wrap type.

Journal of pediatric surgery·2026
Same author

Prenatal diagnosis of esophageal atresia - Still a challenge.

Journal of pediatric surgery·2025
Same author

Golden hour management of infants with congenital diaphragmatic hernia: 15 year experience at a high-volume center.

Journal of perinatology : official journal of the California Perinatal Association·2025
Same author

Intubation and Lower Saturation in the Delivery Room are Associated with Balloon Atrial Septostomy in Neonates with Transposition of the Great Arteries.

The Journal of pediatrics·2024
Same author

Association between initial ventilation mode and hospital outcomes for severe congenital diaphragmatic hernia.

Journal of perinatology : official journal of the California Perinatal Association·2024

Related Experiment Video

Updated: Jan 29, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K

The predictive edge: modeling and simulation in drug product development.

Sanjay Konagurthu1, Dineli T S Ranathunga1, Stephanie Buchanan1

  • 1Thermo Fisher Scientific, 62925 NE 18th Street, Bend, OR 97701, USA.

Advanced Drug Delivery Reviews
|January 27, 2026
PubMed
Summary

In silico predictive modeling and artificial intelligence (AI) accelerate drug development. These computational tools enhance decision-making, improving drug performance and success rates from discovery to commercialization.

Keywords:
AI/MLDrug developmentFormulationPharmacokineticsPredictive stabilityProcess modelingSolubility and bioavailability

More Related Videos

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.8K

Related Experiment Videos

Last Updated: Jan 29, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.8K

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Computational Biology
  • Biotechnology

Background:

  • Drug development is a complex, costly, and time-consuming process with historically low success rates.
  • Traditional trial-and-error methods are inefficient, necessitating advanced approaches.
  • In silico predictive modeling and simulations are emerging as critical tools to de-risk and accelerate drug development.

Purpose of the Study:

  • To review in silico predictive modeling and simulation techniques in drug product development.
  • To emphasize the role of artificial intelligence (AI) and machine learning (ML) in these processes.
  • To highlight applications in drug delivery, formulation, and manufacturing.

Main Methods:

  • Review of current literature on in silico predictive modeling and simulation techniques.
  • Focus on AI and ML algorithms for data analysis and predictive model development.
  • Examination of applications across the drug development pipeline, from discovery to commercialization.

Main Results:

  • In silico tools, particularly AI/ML, are increasingly adopted across drug discovery, delivery, and formulation.
  • These methods enable rapid analysis of large datasets for enhanced prediction and optimization.
  • AI/ML significantly improves classification, prediction, and optimization in drug development.

Conclusions:

  • In silico predictive modeling and AI/ML are transforming drug product development by enhancing efficiency and success rates.
  • These computational approaches are vital for improving drug performance, manufacturability, stability, and safety.
  • Widespread adoption of these technologies promises to streamline the journey from clinical development to market approval.